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Introduction
Genetic counseling of mosaic trisomy at amniocente-
sis is difficult because of the phenotypic variability
associated with the condition; some fetuses exhibit the
typical phenotype, while others are normal [1–3]. Tri-
somy 9, mosaic or non-mosaic, is a relatively uncom-
mon chromosomal abnormality that has characteristic
phenotypic features including growth and mental retar-
dation, dysmorphic faces with low-set malformed ears,
microphthalmia, a bulbous nose and a small mouth, a
high-arched palate, congenital heart defects (most com-
monly ventricular septal defect), genitourinary anomalies
(hypoplastic genitalia, cryptorchidism, cystic kidneys, or
hydronephrosis), skeletal anomalies (joint dislocations
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SUMMARY
Objective: To present prenatal diagnosis and molecular genetic analyses of mosaic trisomy 9.
Materials, Methods and Results: A 35-year-old woman, gravida 3, para 1, underwent amniocentesis at 17 weeks
of gestation because of her advanced maternal age. Amniocentesis revealed a karyotype of 47,XX,+9[3]/
46,XX[6]. Repeat amniocentesis at 19 weeks of gestation revealed a karyotype of 47,XX,+9[6]/46,XX[19]. At 22
weeks of gestation, she was referred to a tertiary medical center for genetic counseling, and amniocentesis
revealed a karyotype of 47,XX,+9[2]/46,XX[22]. Array comparative genomic hybridization analysis of uncul-
tured amniocytes revealed no genomic imbalance in chromosome 9. However, interphase fluorescence in situ
hybridization analysis of uncultured amniocytes showed that nine (18%) of 50 cells were trisomic for chromo-
some 9. Polymorphic DNA marker analyses also revealed a diallelic pattern with unequal biparental inheritance
of chromosome 9 and a dosage ratio of 1:18 (paternal allele:maternal allele) in the uncultured amniocytes and
a dosage ratio of 1:36 in the cultured amniocytes, indicating that the euploid cell line had maternal uniparental
isodisomy for chromosome 9. Level II ultrasound demonstrated bilateral ventriculomegaly. The pregnancy was
subsequently terminated, and a malformed fetus was delivered. Postnatal cytogenetic and polymorphic DNA
marker analyses of the fetal and extraembryonic tissues confirmed the prenatal diagnosis.
Conclusion: Mosaic trisomy 9 carries a high risk of fetal abnormalities warranting detailed sonographic investi-
gation of congenital malformations. Mosaic trisomy 9 can be associated with maternal uniparental disomy for
chromosome 9 in euploid cell lines. Array comparative genomic hybridization is limited for the detection of 
low-level mosaicism. [Taiwan J Obstet Gynecol 2010;49(3):341–350]
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or deformations), and central nervous system anom-
alies (hydrocephalus or Dandy-Walker malformation)
[4–11]. Cases with mosaic trisomy 9 have been re-
ported to be associated with maternal uniparental dis-
omy for chromosome 9 (UPD 9) [12–14]. Here, we
report the prenatal diagnosis and molecular genetic
analyses of mosaic trisomy 9 with maternal isodisomy
of chromosome 9 in a second-trimester fetus with ven-
triculomegaly and facial dysmorphism.
Materials, Methods and Results
A 35-year-old woman, gravida 3, para 1, underwent
amniocentesis at 17 weeks of gestation because of her
advanced maternal age. She had experienced one spon-
taneous abortion and had a 12-year-old healthy son.
Her husband was 38 years old. Both parents were
healthy, and there was no family history of congenital
malformations. In three out of nine separated colonies
of amniocytes, an abnormal karyotype of 47,XX,+9
was found (Figure 1), while the other six colonies had
a karyotype of 46,XX. The cytogenetic result of amnio-
centesis was 47,XX,+9[3]/46,XX[6]. Repeat amniocen-
tesis at 19 weeks of gestation revealed a karyotype of
47,XX,+9[6]/46,XX[19]. She was referred to Mackay
Memorial Hospital for genetic counseling at 22 weeks
of gestation, and amniocentesis was repeated. Cytoge-
netic analysis of cultured amniocytes revealed a karyotype
of 47,XX,+9[2]/46,XX[22]. The parental karyotypes were
normal. Array comparative genomic hybridization
(aCGH) analysis of uncultured amniocytes did not mani-
fest any genomic imbalances in chromosome 9 (Figure 2).
Fluorescence in situ hybridization (FISH) analysis of
uncultured interphase amniocytes using TelVysion 9q
SpectrumOrange DNA probe (Abbott, IL, USA) showed
three signals in nine out of 50 uncultured amniocytes
and two signals in the remaining 41 amniocytes, indi-
cating low-level mosaicism for trisomy 9 (Figure 3).
Quantitative fluorescent polymerase chain reaction
(QF-PCR) analyses of uncultured and cultured amnio-
cytes using informative microsatellite markers specific
for chromosome 9 revealed a diallelic pattern with un-
equal biparental inheritance of chromosome 9 (Figure
4). The uncultured amniocytes had a dosage ratio of
1:18 (paternal allele:maternal allele), and the cultured
amniocytes had a dosage ratio of 1:36. The maternal
allele dosage was much greater than the paternal allele
dosage, indicating that the euploid cell line contained
two homologous chromosomes 9 of maternal origin
and had maternal uniparental isodisomy 9. Trisomy 9
mosaicism in this case was most likely the result of 
a postzygotic mitotic error or less likely the result of
partial trisomic zygote rescue of a meiotic II non-
disjunction error of maternal origin.
At 24 weeks of gestation, level II ultrasound showed
bilateral ventriculomegaly. The parents elected to ter-
minate the pregnancy. A 544 g malformed fetus was
delivered with clenched hands, hypertelorism, a large
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Figure 2. Array comparative genomic hybridization analysis
of uncultured amniocytes shows no genomic imbalance in
chromosome 9.
forehead, bilateral epicanthal folds, a broad nasal bridge,
low-set posteriorly rotated ears, a thin upper lip, micro-
gnathia, and a short neck (Figure 5).
Cytogenetic analyses of the fetal and extraembry-
onic tissues showed a karyotype of 47,XX,+9/46,XX.
The levels of trisomy 9 in the cells of various tissues were
11% (11/100) in the cord blood, 5% (2/40) in the skin,
2.5% (1/40) in the lung, 22.5% (9/40) in the liver, 10%
(4/40) in the cord, 17.5% (7/40) in the amnion, and
100% (40/40) in the placenta. Polymorphic DNA marker
analyses of the uncultured fetal and extraembryonic tis-
sues showed a diallelic pattern with unequal biparental
inheritance of chromosome 9 (Figure 6). The uncultured
tissues of cord, lungs, liver, skin, and cord blood had a
paternal:maternal dosage ratio of 1:6, and the uncul-
tured tissue of placenta had a dosage ratio of 1:2.
Discussion
The present case shows the usefulness of interphase
FISH and QF-PCR, and the limitations of aCGH for
the identification of low-level mosaicism for trisomy 9
at amniocentesis. The interphase FISH proved to be a
very efficient method for confirmation of the status of
mosaicism in the amniotic fluid sample prior to cul-
ture. The QF-PCR assay requires both parental sam-
ples and multiple polymorphic specific loci and shows
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Figure 3. Fluorescence in situ hybridization analysis of uncultured interphase amniocytes shows (A) three signals in a cell with














Figure 4. Representative electrophoretograms of quantita-
tive fluorescent polymerase chain reaction assays. The
marker D9S941 shows two peaks (189 and 205 bp; paternal
and maternal, respectively) of unequal fluorescent activity
from two different parental alleles in uncultured amniocytes
with a dosage ratio of 1:18 (paternal:maternal) and in cul-
tured amniocytes with a dosage ratio of 1:36.
BA
Figure 5. The proband at birth.
limitations for the detection of a very low level of chro-
mosomal mosaicism. Donaghue et al [15] suggested
that the QF-PCR assay can detect mosaicism when the
abnormal cell line comprises at least 15% of the whole
sample. However, in this study, QF-PCR was able 
to detect the low-level mosaicism in uncultured and
cultured amniocytes. aCGH can detect DNA dosage
imbalances, including deletions and duplications, but
shows limitations for the detection of low-level mo-
saicism, balanced translocations, inversions and poly-
ploidy. Recent studies have suggested that aCGH can
detect mosaicism as low as 20% in peripheral blood
cells [16,17]. In this study, aCGH was unable to detect
the low-level mosaicism of 18% (9/50) mosaic trisomy 9
in the uncultured amniocytes.
To date, at least 37 cases of prenatally detected
mosaic trisomy 9 have been reported (Table). Of these
37 cases, 24 (64.9%) were associated with phenotypic
abnormalities, suggesting a high risk of malformation
in fetuses with prenatally detected mosaic trisomy 9.
Among normal prenatal fetuses, the sex ratio is 1.07
(males/females). The Table shows that the sex ratio for
fetal mosaic trisomy 9 is 0.21 (6/29), indicating a female
preponderance in prenatally detected mosaic trisomy
9 and a prenatal selection against mosaic trisomy 
9 males.
UPD can be observed together with a chromoso-
mal aberration. Liehr [31] suggested that at least one-
third of UPD cases are associated with or due to a
chromosomal rearrangement. The phenotypic abnor-
malities of our case are more likely due to low-level
mosaic trisomy 9 rather than the phenotypic effect of
maternal UPD 9, because there is no evidence for an
imprinting locus on maternal chromosome 9 [31–33].
UPD 9 can be associated with major clinical conse-
quences only when a recessive mutation is reduced to
homozygosity [34–36]. Sulisalo et al [34] reported UPD
9 with cartilage-hair hypoplasia because of a homozy-
gous deletion of the CHH gene. Tiranti et al [35] reported
UPD 9 with Leigh syndrome because of a homozygous
loss of function mutation of the SURF-1 gene. Castanet
et al [36] reported maternal UPD 9 with syndromic
congenital hypothyroidism because of homozygosity
for a novel FOXE1 mutation.
Cases with maternal UPD 9 have been reported to
be associated with confined placental mosaicism for
trisomy 9, low-level level II mosaic trisomy 9, low-level
mosaic trisomy 9, and mosaic supernumerary ring
chromosome 9 [r(9)] [12–14, 37]. Wilkinson et al
[13] reported maternal UPD 9 in a fetus with mosaic
trisomy 9 at chorionic villus sampling. Slater et al [14]
reported maternal UPD 9 in a fetus with trisomy 9 at
chorionic villus sampling, level II mosaic trisomy 9
(2.8%, 2 of 71 cells) at amniocentesis, low-level mosaic
trisomy 9 (2.9%, 3 of 102 cells) at cordocentesis, and
low-level mosaic trisomy 9 (8%, 4 of 50 cells) at neona-
tal blood sampling. The case was followed up to 1 year
of age and had minor facial dysmorphism, skeletal ab-
normalities and growth retardation. Willatt et al [12]
reported maternal UPD 9 in a 17-year-old man with
growth and mental retardation, facial dysmorphism,
skeletal abnormalities, and low-level mosaic trisomy 9
(7%, 7 of 100 cells) in the blood. Anderlid et al [37]
reported maternal UPD 9 in a 10-month-old girl
described by Blennow et al [38] with psychomotor
retardation, moderate mental retardation, speech dif-
ficulties, no dysmorphic features, and a supernumer-
ary r(9)(p10p12) in 36% of the lymphocytes. Björch 
et al [32] reported maternal isodisomy of UPD 9 in a
34-year-old woman with isochromosomes for the short
and long arms of chromosome 9 without any clinical
symptoms.
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Figure 6. Representative electrophoretograms of quantita-
tive fluorescent polymerase chain reaction assays. The
marker D9S941 shows two peaks (189 and 205 bp; paternal
and maternal) of unequal fluorescent activity from two dif-
ferent parental alleles in the tissues of cord, lungs, liver, skin
and cord blood with a dosage ratio of 1:6 (paternal:mater-
nal) and in the placenta with a dosage ratio of 1:2.
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In summary, there is a female preponderance in pre-
natally detected mosaic trisomy 9, and mosaic trisomy
9 can be associated with maternal UPD 9 in euploid
cell lines. Mosaic trisomy 9 at amniocentesis carries a
high risk of fetal abnormalities and should include
detailed sonographic investigation of congenital mal-
formations. aCGH shows limitations for the detection
low-level mosaicism, whereas interphase FISH and 
QF-PCR are useful to confirm the status of mosaicism
in the uncultured amniocytes.
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